Biosimilar Newsletter Archive

  1. 05.20.22 -- Enhancing The Patient Experience During Subcutaneous Biologic Delivery 5/20/2022

    05/20/22 Biosimilar Development Newsletter

  2. 05.19.22 -- Post-COVID Supply Chain Strategies For BioPharma 5/19/2022
    05/19/22 Biosimilar Development Newsletter
  3. 05.15.22 -- Celltrion's Remsima Wins Brazilian Tender 5/15/2022
    05/15/22 Biosimilar Development Newsletter
  4. 05.12.22 -- Celltrion's Remsima Wins Brazilian Tender 5/12/2022
    05/12/22 Biosimilar Development Newsletter
  5. 05.06.22 -- mRNA Manufacturing Strategies 5/6/2022

    05/06/22 Biosimilar Development Newsletter

  6. 05.05.22 -- CMC & Quality Considerations When Engaging Your CDMO 5/5/2022
    05/05/22 Biosimilar Development Newsletter
  7. 05.03.22 -- New Episodes: Allogeneic CAR-T Therapies, Antibodies for Severe Allergies, and more. 5/3/2022
    05/03/22 Biosimilar Development Newsletter
  8. 04.28.22 -- Amgen's Ph3 Biosimilar Stelara Trial Boasts Positive Results 4/28/2022
    04/28/22 Biosimilar Development Newsletter
  9. 04.21.22 -- Amneal Achieves Second U.S. Biosimilar Approval 4/21/2022
    04/21/22 Biosimilar Development Newsletter
  10. 04.14.22 -- BioPharma Deal-Making In 2022: Key Trends 4/14/2022
    04/14/22 Biosimilar Development Newsletter